| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 4.15e-07 | 17 | 18 | 3 | GO:0046703 | |
| GeneOntologyMolecularFunction | cholesterol binding | 1.23e-03 | 58 | 18 | 2 | GO:0015485 | |
| GeneOntologyMolecularFunction | sterol binding | 1.84e-03 | 71 | 18 | 2 | GO:0032934 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 3.10e-07 | 16 | 18 | 3 | GO:0002486 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway | 3.77e-07 | 17 | 18 | 3 | GO:0002484 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 3.77e-07 | 17 | 18 | 3 | GO:0002476 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class Ib | 4.52e-07 | 18 | 18 | 3 | GO:0002428 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I | 9.78e-07 | 23 | 18 | 3 | GO:0019885 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 1.27e-06 | 25 | 18 | 3 | GO:0002483 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation via MHC class Ib | 1.27e-06 | 25 | 18 | 3 | GO:0002475 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous antigen | 2.72e-06 | 32 | 18 | 3 | GO:0019883 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class I | 5.83e-06 | 41 | 18 | 3 | GO:0002474 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated cytotoxicity | 6.27e-06 | 42 | 18 | 3 | GO:0001916 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated cytotoxicity | 1.27e-05 | 53 | 18 | 3 | GO:0001914 | |
| GeneOntologyBiologicalProcess | susceptibility to natural killer cell mediated cytotoxicity | 2.58e-05 | 9 | 18 | 2 | GO:0042271 | |
| GeneOntologyBiologicalProcess | T cell mediated cytotoxicity | 2.95e-05 | 70 | 18 | 3 | GO:0001913 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated immunity | 3.48e-05 | 74 | 18 | 3 | GO:0002711 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | 3.77e-05 | 76 | 18 | 3 | GO:0048002 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated cytotoxicity | 4.23e-05 | 79 | 18 | 3 | GO:0001912 | |
| GeneOntologyBiologicalProcess | positive regulation of cell killing | 5.85e-05 | 88 | 18 | 3 | GO:0031343 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated immunity | 1.17e-04 | 111 | 18 | 3 | GO:0002709 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 1.62e-04 | 124 | 18 | 3 | GO:0001910 | |
| GeneOntologyBiologicalProcess | cellular response to exogenous dsRNA | 1.64e-04 | 22 | 18 | 2 | GO:0071360 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation | 2.27e-04 | 139 | 18 | 3 | GO:0019882 | |
| GeneOntologyBiologicalProcess | regulation of cell killing | 2.68e-04 | 147 | 18 | 3 | GO:0031341 | |
| GeneOntologyBiologicalProcess | cellular response to dsRNA | 2.68e-04 | 28 | 18 | 2 | GO:0071359 | |
| GeneOntologyBiologicalProcess | positive regulation of response to tumor cell | 2.68e-04 | 28 | 18 | 2 | GO:0002836 | |
| GeneOntologyBiologicalProcess | positive regulation of immune response to tumor cell | 2.68e-04 | 28 | 18 | 2 | GO:0002839 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 2.84e-04 | 150 | 18 | 3 | GO:0002824 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte mediated immunity | 2.84e-04 | 150 | 18 | 3 | GO:0002708 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response | 3.37e-04 | 159 | 18 | 3 | GO:0002821 | |
| GeneOntologyBiologicalProcess | T cell mediated immunity | 3.62e-04 | 163 | 18 | 3 | GO:0002456 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell activation | 4.21e-04 | 35 | 18 | 2 | GO:0032816 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated immunity | 4.46e-04 | 175 | 18 | 3 | GO:0002705 | |
| GeneOntologyBiologicalProcess | leukocyte mediated cytotoxicity | 5.41e-04 | 187 | 18 | 3 | GO:0001909 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell mediated cytotoxicity | 5.50e-04 | 40 | 18 | 2 | GO:0045954 | |
| GeneOntologyBiologicalProcess | positive regulation of macrophage activation | 6.07e-04 | 42 | 18 | 2 | GO:0043032 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell mediated immunity | 6.66e-04 | 44 | 18 | 2 | GO:0002717 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 8.26e-04 | 49 | 18 | 2 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 8.60e-04 | 50 | 18 | 2 | GO:0002834 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | 1.01e-03 | 232 | 18 | 3 | GO:0002706 | |
| GeneOntologyBiologicalProcess | response to exogenous dsRNA | 1.04e-03 | 55 | 18 | 2 | GO:0043330 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.05e-03 | 235 | 18 | 3 | GO:0002822 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 1.08e-03 | 56 | 18 | 2 | GO:0002418 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell activation | 1.28e-03 | 61 | 18 | 2 | GO:0032814 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response | 1.28e-03 | 252 | 18 | 3 | GO:0002819 | |
| GeneOntologyBiologicalProcess | response to dsRNA | 1.36e-03 | 63 | 18 | 2 | GO:0043331 | |
| GeneOntologyBiologicalProcess | positive regulation of nitric oxide biosynthetic process | 1.45e-03 | 65 | 18 | 2 | GO:0045429 | |
| GeneOntologyBiologicalProcess | positive regulation of nitric oxide metabolic process | 1.54e-03 | 67 | 18 | 2 | GO:1904407 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 1.72e-03 | 71 | 18 | 2 | GO:0002347 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 1.97e-03 | 76 | 18 | 2 | GO:0042269 | |
| GeneOntologyBiologicalProcess | regulation of response to biotic stimulus | 2.02e-03 | 643 | 18 | 4 | GO:0002831 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 2.18e-03 | 80 | 18 | 2 | GO:0002715 | |
| GeneOntologyBiologicalProcess | regulation of macrophage activation | 2.24e-03 | 81 | 18 | 2 | GO:0043030 | |
| GeneOntologyBiologicalProcess | cell killing | 2.26e-03 | 307 | 18 | 3 | GO:0001906 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated immunity | 2.30e-03 | 309 | 18 | 3 | GO:0002703 | |
| GeneOntologyBiologicalProcess | positive regulation of immune effector process | 2.47e-03 | 317 | 18 | 3 | GO:0002699 | |
| GeneOntologyBiologicalProcess | regulation of nitric oxide biosynthetic process | 3.19e-03 | 97 | 18 | 2 | GO:0045428 | |
| GeneOntologyBiologicalProcess | regulation of nitric oxide metabolic process | 3.38e-03 | 100 | 18 | 2 | GO:0080164 | |
| GeneOntologyBiologicalProcess | positive regulation of type II interferon production | 3.59e-03 | 103 | 18 | 2 | GO:0032729 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | 3.72e-03 | 105 | 18 | 2 | GO:0042267 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immunity | 4.01e-03 | 109 | 18 | 2 | GO:0002228 | |
| GeneOntologyBiologicalProcess | defense response to symbiont | 4.04e-03 | 1286 | 18 | 5 | GO:0140546 | |
| GeneOntologyBiologicalProcess | nitric oxide biosynthetic process | 4.22e-03 | 112 | 18 | 2 | GO:0006809 | |
| GeneOntologyBiologicalProcess | nitric oxide metabolic process | 4.91e-03 | 121 | 18 | 2 | GO:0046209 | |
| GeneOntologyBiologicalProcess | reactive nitrogen species metabolic process | 5.07e-03 | 123 | 18 | 2 | GO:2001057 | |
| GeneOntologyBiologicalProcess | natural killer cell activation | 5.15e-03 | 124 | 18 | 2 | GO:0030101 | |
| GeneOntologyBiologicalProcess | positive regulation of immune response | 5.40e-03 | 845 | 18 | 4 | GO:0050778 | |
| GeneOntologyBiologicalProcess | positive regulation of innate immune response | 5.45e-03 | 420 | 18 | 3 | GO:0045089 | |
| GeneOntologyBiologicalProcess | defense response to other organism | 5.94e-03 | 1407 | 18 | 5 | GO:0098542 | |
| GeneOntologyBiologicalProcess | macrophage activation | 6.52e-03 | 140 | 18 | 2 | GO:0042116 | |
| GeneOntologyBiologicalProcess | lymphocyte mediated immunity | 6.56e-03 | 449 | 18 | 3 | GO:0002449 | |
| GeneOntologyBiologicalProcess | positive regulation of response to biotic stimulus | 6.64e-03 | 451 | 18 | 3 | GO:0002833 | |
| GeneOntologyBiologicalProcess | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 7.09e-03 | 462 | 18 | 3 | GO:0002460 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 8.71e-04 | 519 | 18 | 4 | GO:0009897 | |
| GeneOntologyCellularComponent | cell surface | 2.01e-03 | 1111 | 18 | 5 | GO:0009986 | |
| Domain | MHC_I_a_a1/a2 | 9.89e-07 | 21 | 18 | 3 | IPR001039 | |
| Domain | MHC_I | 9.89e-07 | 21 | 18 | 3 | PF00129 | |
| Domain | - | 1.50e-06 | 24 | 18 | 3 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 1.50e-06 | 24 | 18 | 3 | IPR011161 | |
| Domain | MHC_I/II-like_Ag-recog | 6.21e-06 | 38 | 18 | 3 | IPR011162 | |
| Domain | IG_MHC | 1.50e-03 | 60 | 18 | 2 | PS00290 | |
| Domain | Znf_RING_CS | 1.06e-02 | 163 | 18 | 2 | IPR017907 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | 1.19e-04 | 93 | 15 | 3 | M26985 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 3.75e-04 | 137 | 15 | 3 | M5669 | |
| Pubmed | 2.33e-09 | 6 | 18 | 3 | 10894171 | ||
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 12782710 | ||
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 26982091 | ||
| Pubmed | The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia. | 7.59e-07 | 3 | 18 | 2 | 20428196 | |
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 18791713 | ||
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 25212604 | ||
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 21857986 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 19081632 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 12756263 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 8882725 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 25775242 | ||
| Pubmed | Direct interaction of the mouse cytomegalovirus m152/gp40 immunoevasin with RAE-1 isoforms. | 1.52e-06 | 4 | 18 | 2 | 20166740 | |
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 12421908 | ||
| Pubmed | 2.53e-06 | 5 | 18 | 2 | 8982867 | ||
| Pubmed | MULT1E/mIL-12: a novel bifunctional protein for natural killer cell activation. | 2.53e-06 | 5 | 18 | 2 | 24572784 | |
| Pubmed | Polymorphisms of NKG2D ligands: diverse RAET1/ULBP genes in northeastern Thais. | 3.79e-06 | 6 | 18 | 2 | 19688209 | |
| Pubmed | Crystal structures of RAE-1beta and its complex with the activating immunoreceptor NKG2D. | 3.79e-06 | 6 | 18 | 2 | 11825567 | |
| Pubmed | 3.79e-06 | 6 | 18 | 2 | 20976056 | ||
| Pubmed | 3.79e-06 | 6 | 18 | 2 | 20219610 | ||
| Pubmed | 3.79e-06 | 6 | 18 | 2 | 11491531 | ||
| Pubmed | Ligands for murine NKG2D display heterogeneous binding behavior. | 3.79e-06 | 6 | 18 | 2 | 11857333 | |
| Pubmed | 5.30e-06 | 7 | 18 | 2 | 25583577 | ||
| Pubmed | 5.30e-06 | 7 | 18 | 2 | 28559451 | ||
| Pubmed | The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. | 5.30e-06 | 7 | 18 | 2 | 16831899 | |
| Pubmed | 5.30e-06 | 7 | 18 | 2 | 20870941 | ||
| Pubmed | 5.30e-06 | 7 | 18 | 2 | 25883935 | ||
| Pubmed | 5.30e-06 | 7 | 18 | 2 | 26151313 | ||
| Pubmed | NKG2D and Its Ligand MULT1 Contribute to Disease Progression in a Mouse Model of Multiple Sclerosis. | 5.30e-06 | 7 | 18 | 2 | 30787931 | |
| Pubmed | 5.30e-06 | 7 | 18 | 2 | 11239445 | ||
| Pubmed | 5.30e-06 | 7 | 18 | 2 | 12370332 | ||
| Pubmed | A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity. | 7.07e-06 | 8 | 18 | 2 | 12645935 | |
| Pubmed | Gut microbiota regulates NKG2D ligand expression on intestinal epithelial cells. | 9.09e-06 | 9 | 18 | 2 | 23136011 | |
| Pubmed | Cutting edge: Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor. | 9.09e-06 | 9 | 18 | 2 | 14764662 | |
| Pubmed | A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3. | 1.14e-05 | 10 | 18 | 2 | 11827464 | |
| Pubmed | Cell Surface Downregulation of NK Cell Ligands by Patient-Derived HIV-1 Vpu and Nef Alleles. | 1.39e-05 | 11 | 18 | 2 | 26656785 | |
| Pubmed | Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. | 1.09e-04 | 30 | 18 | 2 | 21946350 | |
| Pubmed | 2.05e-04 | 41 | 18 | 2 | 8724849 | ||
| Interaction | RAET1L interactions | 5.84e-05 | 13 | 18 | 2 | int:RAET1L | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q25 | 1.87e-03 | 164 | 18 | 2 | chr6q25 | |
| GeneFamily | Ring finger proteins | 1.61e-02 | 275 | 13 | 2 | 58 | |
| Drug | Chloroprene | 4.48e-05 | 1348 | 18 | 7 | ctd:D002737 | |
| Drug | eckol | 4.58e-05 | 13 | 18 | 2 | ctd:C060311 | |
| Disease | level of UL16-binding protein 6 in blood serum | 3.51e-07 | 2 | 18 | 2 | OBA_2043185 | |
| Disease | brain aneurysm | 4.28e-05 | 113 | 18 | 3 | EFO_0003870 | |
| Disease | pulmonary function measurement, forced expiratory volume | 2.31e-04 | 37 | 18 | 2 | EFO_0003892, EFO_0004314 | |
| Disease | Polydactyly | 2.29e-03 | 117 | 18 | 2 | C0152427 | |
| Disease | keratinocyte carcinoma | 2.33e-03 | 118 | 18 | 2 | EFO_0010176 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LPLCLACLVCVFLLM | 361 | Q9HCE9 | |
| LLALPLAAPSCPMLC | 21 | Q86UN3 | |
| ICLLCKEMCGSPAPL | 11 | Q2Q1W2 | |
| CISLMGCLLLLLCTP | 196 | Q8WVP7 | |
| LLLILAPLLLLLCCC | 641 | Q86SJ6 | |
| MGLLLPLALCILVLC | 1 | Q9UGM5 | |
| PCRLQFLLLLLMLGC | 11 | Q8N3T1 | |
| AMPCFVIIIILCVPC | 316 | Q29980 | |
| PFLLLATPFVLCCKC | 266 | P50876 | |
| PAACLNFNCMLILLP | 56 | P04839 | |
| CILACCYPLLKLPLP | 36 | Q12770 | |
| GLCYLCLPMLQSLPL | 361 | Q6ZSM3 | |
| LGILLFLLCCPLMVL | 201 | Q96AM1 | |
| FLLCCPLMVLPCLAL | 206 | Q96AM1 | |
| LCCVLGLLFIILMPL | 111 | O43490 | |
| YCPRMILRSLCPCVL | 571 | Q6P1J6 | |
| MSCPVPACCALLLVL | 1 | P51688 | |
| PICPGLICCLLTCLL | 66 | Q6XCG6 | |
| LCCLLIILPCFILPG | 231 | Q5VY80 | |
| LCCLLIILPCFILPG | 231 | Q9BZM5 |